logo-loader
viewAmryt Pharma PLC

Investor Update: Amryt Pharma's AP101 given fast-track status by US regulator

Headlines from the Proactive UK newsroom.

Amryt Pharma (LON:AMYT) has received fast track designation from the US FDA for its treatment for skin disease EB. The FDA recognised that EB is a serious disease and that there are no FDA-approved treatments for this condition.

Shanta Gold (LON:SHG) has intersected high grades over sizeable widths from its latest surface exploration drilling at the New Luika mine in Tanzania. Shanta said these results coupled with the next round of drilling should be sufficient to declare new resources at two new targets in future 

Anglo Asian Mining (LON:AAZ) has entertained a delegation from the British Embassy in Azerbaijan at its Gedabek gold, copper and silver mine. Anglo Asian’s the largest mining investor in Azerbaijan and the second largest British investor after BP.

Argos chief executive John Rogers is to leave the Sainsbury’s subsidiary to become chief financial officer of ad group WPP. Rogers’ last day will be 31 October.

Bakery chain Greggs has racked up another quarter of impressive sales. Revenues rose by 12% in the three months to September and by 7.4% on a like-for-like basis. Greens also opened its 2,000th outlet during the period. 

JD Sports’ acquisition of Footasylum is to face a full competition authority inquiry. JD firmly believes there will no impact on competition so offered no remedies to avoid a full reference, hence the CMA today confirmed there will be a phase 2 investigation.

Quick facts: Amryt Pharma PLC

Price: 198 GBX

AIM:AMYT
Market: AIM
Market Cap: £305.91 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Amryt Pharma PLC named herein, including the promotion by the Company of Amryt Pharma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amryt Pharma PLC: Proactive One2One Virtual Event

Amryt Pharma PLC's (LON:AMYT) Joe Wiley pitches the company to investors at the Proactive One2One Virtual Event. Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan...

3 weeks, 2 days ago

2 min read